We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

256 hedge funds and large institutions have $561M invested in Editas Medicine in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 71 increasing their positions, 74 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.94% more ownership

Funds ownership: 66.23% → 69.17% (+2.9%)

9% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 35

0% more funds holding

Funds holding: 256 → 256 (0)

4% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 74

5% less call options, than puts

Call options by funds: $19.9M | Put options by funds: $20.8M

35% less capital invested

Capital invested by funds: $862M → $561M (-$301M)

Holders
256
Holders Change
–
Holders Change %
0%
% of All Funds
4.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
71
Reduced
74
Closed
35
Calls
$19.9M
Puts
$20.8M
Net Calls
-$968K
Net Calls Change
+$6.68M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$32.2M
2
WP
Woodline Partners
California
+$13.3M
3
Citadel Advisors
Citadel Advisors
Florida
+$9.02M
4
PHS
PFM Health Sciences
California
+$8.44M
5
BlackRock
BlackRock
New York
+$6.02M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$17.2M
2
Millennium Management
Millennium Management
New York
-$7.99M
3
AIM
ARK Investment Management
Florida
-$7.29M
4
CU
CQS (US)
New York
-$6.41M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$4.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
126
Erste Asset Management
Austria
$183K – – –
SPAS
127
Spectrum Planning & Advisory Services
California
$178K – – –
CC
128
Corton Capital
Ontario, Canada
$172K +$38.9K +2,901 +25%
ACM
129
AlphaCrest Capital Management
New York
$167K -$148K -11,052 -44%
KFGK
130
Keystone Financial Group (Kentucky)
Kentucky
$166K +$188K +14,000 New
Janus Henderson Group
131
Janus Henderson Group
United Kingdom
$162K -$335 -25 -0.2%
ProShare Advisors
132
ProShare Advisors
Maryland
$154K -$91.2K -6,807 -34%
Public Employees Retirement Association of Colorado
133
Public Employees Retirement Association of Colorado
Colorado
$138K – – –
CIC
134
Cornercap Investment Counsel
Georgia
$138K +$156K +11,665 New
PI
135
PEAK6 Investments
Illinois
$136K +$221K +16,500 New
Principal Financial Group
136
Principal Financial Group
Iowa
$134K -$16.4K -1,223 -10%
Teacher Retirement System of Texas
137
Teacher Retirement System of Texas
Texas
$130K -$41K -3,057 -22%
Man Group
138
Man Group
United Kingdom
$130K – – –
Baird Financial Group
139
Baird Financial Group
Wisconsin
$125K -$3.55K -265 -2%
CPO
140
Cerity Partners OCIO
New York
$124K – – –
LFM
141
Lumina Fund Management
New York
$124K – – –
HSA
142
Hussman Strategic Advisors
Maryland
$123K – – –
VEA
143
Virtus ETF Advisers
New York
$123K +$66.3K +4,945 +91%
CAN
144
Cetera Advisor Networks
California
$123K +$139K +10,391 New
AG
145
Algert Global
California
$122K -$20.8K -1,550 -13%
BWP
146
BSW Wealth Partners
Colorado
$122K +$138K +10,305 New
AB
147
Amalgamated Bank
New York
$103K -$32.7K -2,442 -22%
Lazard Asset Management
148
Lazard Asset Management
New York
$102K -$1.56M -116,226 -93%
PCM
149
Penserra Capital Management
California
$101K +$10.7K +800 +10%
Federated Hermes
150
Federated Hermes
Pennsylvania
$67K +$76.2K +5,687 New
4 5
6
7 8

EDIT Hedge Fund Activity: Q2 2022 in Review

256 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2022, worth a combined $561M — down 35% from $862M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new EDIT positions and 35 closed out — a net gain of 3 holders — while 71 added to existing stakes and 74 trimmed.

The largest buyer was State Street, adding an estimated $32.2M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $17.2M sold.

  • 256 institutional investors held Editas Medicine (EDIT) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $561M of Editas Medicine stock for Q2 2022, down 35% quarter-over-quarter.
  • 38 funds opened new Editas Medicine positions in Q2 2022 and 35 closed out, a net change of +3 holders.
  • The largest Editas Medicine buyer in Q2 2022 was State Street, an estimated $32.2M added.
  • The largest Editas Medicine seller in Q2 2022 was Renaissance Technologies, an estimated $17.2M sold.

Based on aggregated 13F filings for Q2 2022.